Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
78 hedge funds and large institutions have $256M invested in Accelerate Diagnostics in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 6 closing their positions.
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
10% more capital invested
Capital invested by funds: $233M → $256M (+$23.7M)
10% more funds holding
Funds holding: 71 → 78 (+7)
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
23% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $1.44M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OWP
Obermeyer Wealth Partners
Aspen,
Colorado
|
+$5.92M |
| 2 |
MGM
Miura Global Management
New York
|
+$3.96M |
| 3 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$1.93M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.78M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sandler Capital Management
New York
|
-$2.73M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.14M |
| 3 |
Goldman Sachs
New York
|
-$756K |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$321K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$240K |
AXDX Hedge Fund Activity: Q4 2014 in Review
78 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2014, worth a combined $256M — up 10% from $233M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new AXDX positions and 6 closed out — a net gain of 10 holders — while 21 added to existing stakes and 26 trimmed.
The largest buyer was Obermeyer Wealth Partners, opening a new position worth an estimated $5.92M. The largest seller was Sandler Capital Management, exiting entirely with an estimated $2.73M sold.
- 78 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2014, up from 71 in Q3 2014.
- Funds reported $256M of Accelerate Diagnostics stock for Q4 2014, up 10% quarter-over-quarter.
- 16 funds opened new Accelerate Diagnostics positions in Q4 2014 and 6 closed out, a net change of +10 holders.
- The largest Accelerate Diagnostics buyer in Q4 2014 was Obermeyer Wealth Partners, an estimated $5.92M added.
- The largest Accelerate Diagnostics seller in Q4 2014 was Sandler Capital Management, an estimated $2.73M sold.
Based on aggregated 13F filings for Q4 2014.